D A Leffler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D A Leffler

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

The American Journal of Gastroenterology|September 9, 2014

Response to Aziz et alToufic A Kabbani, R R Vanga, D A Leffler, et al.

Alimentary Pharmacology & Therapeutics|February 10, 2012

Body mass index and the risk of obesity in coeliac disease treated with the gluten-free dietT A Kabbani, A Goldberg, C P Kelly, et al.

The Journal of Antimicrobial Chemotherapy|January 25, 2017

Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortalityI Patel, M Wungjiranirun, T Theethira, et al.

Alimentary Pharmacology & Therapeutics|January 23, 2013

Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' replyC P Kelly, P H R Green, J A Murray, et al.

Alimentary Pharmacology & Therapeutics|November 21, 2012

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.

Alimentary Pharmacology & Therapeutics|August 4, 2016

Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registryA Rubio-Tapia, G Malamut, W H M Verbeek, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

The American Journal of Gastroenterology|September 9, 2014

Response to Aziz et alToufic A Kabbani, R R Vanga, D A Leffler, et al.

Alimentary Pharmacology & Therapeutics|February 10, 2012

Body mass index and the risk of obesity in coeliac disease treated with the gluten-free dietT A Kabbani, A Goldberg, C P Kelly, et al.

The Journal of Antimicrobial Chemotherapy|January 25, 2017

Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortalityI Patel, M Wungjiranirun, T Theethira, et al.

Alimentary Pharmacology & Therapeutics|January 23, 2013

Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' replyC P Kelly, P H R Green, J A Murray, et al.

Alimentary Pharmacology & Therapeutics|November 21, 2012

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled studyC P Kelly, P H R Green, J A Murray, et al.

Alimentary Pharmacology & Therapeutics|August 4, 2016

Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registryA Rubio-Tapia, G Malamut, W H M Verbeek, et al.

Pageof 2